Article de revue
Age of human papillomavirus vaccination?
Evidence is overwhelming to show that prophylactic human papillomavirus (HPV) vaccines are very safe and highly efficacious in the prevention of HPV infections and related cervical precancerous lesions detected by cytology in clinical trials and HPV-vaccinated populations. These precancerous lesions, when detected by cytology and treated in a timely manner, have been credited with reductions in cervical cancer incidence and mortality. Thus, it is simply a matter of time before HPV vaccination will be shown to reduce cervical cancer and other HPV-related cancers.
Auteurs
Langues
- Anglais
Année de publication
2016
Journal
The Lancet Infectious Diseases
Volume
10
Type
Article de revue
Catégories
- Prestation de services
Mots-clés
- Suivi de la couverture
- Introduction de nouveaux vaccins
